Literature DB >> 21946200

[MicroRNA-29 and fibrosis diseases].

Yan Ge1, Guochun Chen, Lin Sun, Fuyou Liu.   

Abstract

MicroRNAs (miRNAs,miR) are small, noncoding RNAs with 21-23 nucleotides. MicroRNA-29 (miR-29), a newly discovered miRNAs, is closely related with fibrosis diseases. MiR-29 directly suppresses the expression of a variety of extracellular matrix components and regulates signaling pathways associated with fibrosis. The serum level of miR-29 in patients with liver disease is consistent with the degree of liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946200     DOI: 10.3969/j.issn.1672-7347.2011.09.017

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  6 in total

1.  A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.

Authors:  Youwen Tan; Guohong Ge; Tengli Pan; Danfeng Wen; Li Chen; Xuejun Yu; Xinbei Zhou; Jianhe Gan
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

2.  Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Authors:  Youwen Tan; Tengli Pan; Yun Ye; Guohong Ge; Li Chen; Danfeng Wen; Shengqiang Zou
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

3.  A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.

Authors:  Youwen Tan; Guohong Ge; Tengli Pan; Danfeng Wen; Jianhe Gan
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

4.  Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.

Authors:  Moustafa Nouh Elemeery; Ahmed Noah Badr; Marwa Anwar Mohamed; Doaa Ahmed Ghareeb
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

Review 5.  Serum non-coding RNAs for diagnosis and stage of liver fibrosis.

Authors:  Chao Liu; Xueyun Hou; Kaixin Mo; Nannan Li; Cheng An; Guijian Liu; Zongdai Pan
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

6.  Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin.

Authors:  Sanaz Javanmardi; Ali Mohammad Tamaddon; Mahmoud Reza Aghamaali; Ladan Ghahramani; Samira Sadat Abolmaali
Journal:  Asian J Pharm Sci       Date:  2018-12-01       Impact factor: 6.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.